Mingyi Zhou

614 total citations
26 papers, 442 citations indexed

About

Mingyi Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mingyi Zhou has authored 26 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mingyi Zhou's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (3 papers) and RNA modifications and cancer (3 papers). Mingyi Zhou is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (3 papers) and RNA modifications and cancer (3 papers). Mingyi Zhou collaborates with scholars based in China and United States. Mingyi Zhou's co-authors include Dong Xu, Jay J. Thelen, Marián Hajdúch, Trupti Joshi, Danbo Wang, Mingjie Chen, Ganesh Kumar Agrawal, Ping Yu, Ján A. Miernyk and Brian Mooney and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and PLANT PHYSIOLOGY.

In The Last Decade

Mingyi Zhou

23 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyi Zhou China 9 271 118 106 106 52 26 442
Qiao‐Yang Sun Singapore 15 446 1.6× 80 0.7× 105 1.0× 79 0.7× 19 0.4× 23 675
Warren Wu United States 10 568 2.1× 182 1.5× 89 0.8× 82 0.8× 35 0.7× 15 705
Jin Luo China 16 503 1.9× 255 2.2× 61 0.6× 248 2.3× 16 0.3× 24 768
Y Goto Japan 12 292 1.1× 86 0.7× 171 1.6× 244 2.3× 10 0.2× 30 651
Pan Xie China 12 249 0.9× 85 0.7× 55 0.5× 155 1.5× 14 0.3× 24 405
Jin Gyoung Jung South Korea 14 356 1.3× 97 0.8× 64 0.6× 46 0.4× 10 0.2× 24 509
Charles C. Valentine United States 11 232 0.9× 238 2.0× 37 0.3× 56 0.5× 6 0.1× 21 414
James A. Dowdle United States 6 439 1.6× 128 1.1× 86 0.8× 36 0.3× 8 0.2× 7 606
Gang Yan United States 16 233 0.9× 55 0.5× 110 1.0× 22 0.2× 8 0.2× 36 566

Countries citing papers authored by Mingyi Zhou

Since Specialization
Citations

This map shows the geographic impact of Mingyi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Zhou more than expected).

Fields of papers citing papers by Mingyi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Zhou. The network helps show where Mingyi Zhou may publish in the future.

Co-authorship network of co-authors of Mingyi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyi Zhou. A scholar is included among the top collaborators of Mingyi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyi Zhou. Mingyi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Feng, Mingyi Zhou, Wei Chen, et al.. (2025). N6-methyladenosine modification of host Hsc70 attenuates nucleopolyhedrovirus infection in the lepidopteran model insect Bombyx mori. International Journal of Biological Macromolecules. 298. 139869–139869. 1 indexed citations
2.
Zhang, Yong, Dongmei Huang, Yue Sun, et al.. (2025). 915O KRAS G12D inhibitor HRS-4642 in patients with KRAS G12D-mutant advanced solid tumors: A phase I trial. Annals of Oncology. 36. S558–S559.
3.
Zhou, Mingyi, Yan Gao, Yong Zhang, et al.. (2025). CircZFR/YTHDF3 axis drives lymph node metastasis in cervical cancer via FASN translation. Molecular Cancer. 24(1). 218–218.
4.
Gu, Weihong, et al.. (2025). Single-cell antigen receptor sequencing in pigs with influenza. Communications Biology. 8(1). 1108–1108.
5.
Zhang, Xin, Xiao Cong, Yi Liu, et al.. (2025). Viral Load Dynamics of Chikungunya Virus in Human Specimens — Foshan City, Guangdong Province, China, 2025. China CDC Weekly. 7(33). 1067–1072. 1 indexed citations
6.
Skidmore, Zachary L., Hans Rindt, Shirley Chu, et al.. (2024). Single-cell T-cell receptor repertoire profiling in dogs. Communications Biology. 7(1). 484–484. 3 indexed citations
7.
Geng, Wenjing, Feng Chen, Mingyi Zhou, et al.. (2024). Transgenic silkworm expressing bioactive human ciliary neurotrophic factor for biomedical application. Insect Science. 32(3). 809–820. 1 indexed citations
8.
Guo, Hao, Feng Chen, Mingyi Zhou, et al.. (2023). CRISPR-Cas9-Mediated Mutation of Methyltransferase METTL4 Results in Embryonic Defects in Silkworm Bombyx mori. International Journal of Molecular Sciences. 24(4). 3468–3468. 4 indexed citations
9.
Fan, Huijie, Qiang Wang, Wentao Li, et al.. (2022). Local Label Point Correction for Edge Detection of Overlapping Cervical Cells. Frontiers in Neuroinformatics. 16. 895290–895290. 10 indexed citations
10.
Zhou, Mingyi, Zhuo Yang, Danbo Wang, Peng Chen, & Yong Zhang. (2021). The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex. Journal of Experimental & Clinical Cancer Research. 40(1). 48–48. 50 indexed citations
11.
12.
Yu, Ping, Mingyi Zhou, Jinglei Qu, et al.. (2018). The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients. BMC Cancer. 18(1). 1076–1076. 13 indexed citations
13.
Zhou, Mingyi, Lingyu Fu, Lu Zhang, & Jingdong Zhang. (2018). Ranking the efficacies of FOLFOX and FOLFIRI with or without anti-EGFR therapy or bevacizumab in wild-type-RAS metastatic colorectal cancer according to primary tumor location: A network meta-analysis.. Journal of Clinical Oncology. 36(15_suppl). e15529–e15529. 2 indexed citations
14.
Zhou, Mingyi, et al.. (2018). Tumor regression grading after neoadjuvant chemotherapy predicts long-term outcome of stage IIIC epithelial ovarian cancer.. Journal of Clinical Oncology. 36(15_suppl). 5547–5547. 1 indexed citations
15.
16.
Yan, Yuanyuan, Miao He, Qinghuan Xiao, et al.. (2015). Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway. Oncology Reports. 35(2). 912–922. 31 indexed citations
17.
Givan, Scott A., et al.. (2015). Genome Sequences of Pseudoalteromonas Strains ATCC BAA-314, ATCC 70018, and ATCC 70019. Genome Announcements. 3(3). 4 indexed citations
18.
Zhou, Mingyi, et al.. (2013). Phase III Trials of Standard Chemotherapy with or without Bevacizumab for Ovarian Cancer: A Meta-Analysis. PLoS ONE. 8(12). e81858–e81858. 37 indexed citations
19.
Zhao, Lin, Mengtao Ma, Xuefeng Bai, et al.. (2013). MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Research and Treatment. 139(3). 717–730. 88 indexed citations
20.
Bai, Xuefeng, Feng Jin, Zhaojin Yu, et al.. (2011). Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients. Medical Oncology. 29(3). 1543–1553. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiao‐Yang Sun Breakdown of academic impact, for papers by Warren Wu Breakdown of academic impact, for papers by Jin Luo Breakdown of academic impact, for papers by Y Goto Breakdown of academic impact, for papers by Pan Xie Breakdown of academic impact, for papers by Jin Gyoung Jung Breakdown of academic impact, for papers by Charles C. Valentine Breakdown of academic impact, for papers by James A. Dowdle Breakdown of academic impact, for papers by Gang Yan
Rankless by CCL
2026